Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.

He, Wanbing; Shu, Xiaorong; Zhu, Enyi; Deng, Bingqing; Lin, Yongqing; Wu, Xiaoying; Zhou, Zenan; Wang, Jingfeng; Nie, Ruqiong

He, Wanbing; Shu, Xiaorong; Zhu, Enyi; Deng, Bingqing; Lin, Yongqing; Wu, Xiaoying; Zhou, Zenan; Wang, Jingfeng; Nie, Ruqiong.

Afiliação

He W; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Shu X; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Zhu E; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Deng B; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Lin Y; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Wu X; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Zhou Z; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Wang J; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China.
Nie R; Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, 107 Yanjiang West Rd., Guangzhou, 510120, Guangdong Province, China. nieruqiong@163.com.

BMC Cardiovasc Disord ; 21(1): 75, 2021 02 05.

Article em En | MEDLINE | ID: mdl-33546595

Assuntos

Clopidogrel/uso terapêutico; Doença da Artéria Coronariana/tratamento farmacológico; Hemorragia Gastrointestinal/prevenção & controle; Inibidores da Agregação Plaquetária/uso terapêutico; Inibidores da Bomba de Prótons/uso terapêutico; China; Clopidogrel/efeitos adversos; Doença da Artéria Coronariana/diagnóstico; Doença da Artéria Coronariana/mortalidade; Feminino; Hemorragia Gastrointestinal/induzido quimicamente; Hemorragia Gastrointestinal/diagnóstico; Hemorragia Gastrointestinal/mortalidade; Humanos; Masculino; Pessoa de Meia-Idade; Inibidores da Agregação Plaquetária/efeitos adversos; Inibidores da Bomba de Prótons/efeitos adversos; Estudos Retrospectivos; Medição de Risco; Fatores de Risco; Fatores de Tempo; Resultado do Tratamento

Palavras-chave

Clinical outcomes; Clopidogrel; Coronary heart disease; Gastrointestinal bleeding; NACE; Proton pump inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Inibidores da Bomba de Prótons / Clopidogrel / Hemorragia Gastrointestinal Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google